NSE ScannerComparison · NSE · data 2026-11-01
Nureca Ltd. vs Q-Line Biotech Limited
In plain words
Size: Q-Line Biotech Limited is about 4.2 times the market value of Nureca Ltd..
Return on equity: Q-Line Biotech Limited 25.6% vs Nureca Ltd. 1.1%.
Debt to equity: Q-Line Biotech Limited 0.92 vs Nureca Ltd. 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| NURECA | QLINE | |
|---|---|---|
| Price | ₹293.8 | ₹512.75 |
| Market cap | ₹285 cr | ₹1,196 cr |
| P/E | 61.1 | — |
| P/B | 1.5 | — |
| ROE | 1.1% | 25.6% |
| ROCE | 3.4% | 27.9% |
| Debt / equity | 0.01 | 0.92 |
| Operating margin | 7.0% | — |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 9.7% | 23.2% |
| Profit growth, 3 years (yearly) | — | 20.2% |
| 1-year return | 13.0% | 13.4% |
| Revenue, last 12 months | ₹174 cr | — |
| Net profit, last 12 months | ₹5 cr | — |
| Latest quarter | Sept 2026 | — |
| Quarter net profit | ₹4 cr | — |
| Quarter profit vs a year earlier | +11.6% | — |
| Promoter holding | 70.68% | — |
| Health check | Average (4.4/10) | Strong (7.6/10) |
Common questions
Which earns a higher return on equity?
Q-Line Biotech Limited (25.6% against 1.1%).
Which carries more debt?
Q-Line Biotech Limited has the higher debt-to-equity ratio (0.92 against 0.01).